dabigatran has been researched along with fibrin in 16 studies
| Studies (dabigatran) | Trials (dabigatran) | Recent Studies (post-2010) (dabigatran) | Studies (fibrin) | Trials (fibrin) | Recent Studies (post-2010) (fibrin) |
|---|---|---|---|---|---|
| 3,887 | 261 | 3,490 | 15,994 | 328 | 3,808 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (87.50) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Ammollo, CT; Colucci, M; Incampo, F; Semeraro, F; Semeraro, N | 1 |
| Hoylaerts, MF; Kauskot, A; Peetermans, WE; Schneewind, O; van Ryn, J; Vanassche, T; Verhaegen, J; Verhamme, P | 1 |
| Castellino, FJ; Davis, PK; Mitra, R; Musunuru, H; Ploplis, V; Walsh, M | 1 |
| Hoylaerts, MF; Missiakas, DM; Peetermans, M; Peetermans, WE; Schneewind, O; Van Aelst, LN; Vanassche, T; Verhaegen, J; Verhamme, P | 1 |
| Hosokawa, K; Koide, T; Maruyama, I; Miura, N; Ohnishi, T; Sameshima, H; Tanaka, KA | 1 |
| Flick, MJ; Joshi, N; Kassel, KM; Kopec, AK; Luyendyk, JP; Sullivan, BP; Towery, KL | 1 |
| Arellano-Rodrigo, E; Carné, X; Díaz-Ricart, M; Escolar, G; Galan, AM; Lopez-Vilchez, I; Lozano, M; Molina, P; Reverter, JC; Tassies, D; Villalta, J | 1 |
| Fredenburgh, JC; Leslie, BA; Stafford, AR; Weitz, JI; Yeh, CH | 1 |
| Claushuis, TA; de Stoppelaar, SF; Ottenhoff, R; Roelofs, JJ; Stroo, I; van der Poll, T; Van't Veer, C | 1 |
| Abrahams, SR; Divanovic, S; Flick, MJ; Goss, A; Kopec, AK; Luyendyk, JP; Mackman, N; Mullins, ES; Owens, AP; Palumbo, JS; Thornton, S; van Ryn, J; Weiler, H | 1 |
| Chan, CC; Hou, MC; Hsieh, YC; Hsu, WF; Huang, YH; Lee, KC; Lin, HC; Yang, YY | 1 |
| Antropova, IP; Reino, EV; Yushkov, BG | 1 |
| Arellano-Rodrigo, E; Badimon, JJ; Díaz-Ricart, M; Escolar, G; Fernandez-Gallego, V; López-Vilchez, I; Molina, P; van Ryn, J; Zafar, MU | 1 |
| Callejas, S; Ceron, C; Cortes-Canteli, M; Fernandez-Nueda, I; Fuster, V; Ibanez, B; Jno-Charles, OC; Kruyer, A; Marcos-Diaz, A; Norris, EH; Richards, AT; Rodriguez, I; Ruiz-Cabello, J; Sanchez-Gonzalez, J; Strickland, S | 1 |
| Grossmann, K | 1 |
| Angona, RE; Baldzizhar, A; Eaton, MP; Feng, C; Lebedko, N; Nadtochiy, SM; Stefanos, T | 1 |
1 review(s) available for dabigatran and fibrin
| Article | Year |
|---|---|
Alzheimer's Disease-Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antithrombins; Dabigatran; Fibrin; Hemostasis; Humans; Thrombin | 2021 |
1 trial(s) available for dabigatran and fibrin
| Article | Year |
|---|---|
Coagulation Factor Concentrates Fail to Restore Alterations in Fibrin Formation Caused by Rivaroxaban or Dabigatran in Studies With Flowing Blood From Treated Healthy Volunteers.
Topics: Adult; Anticoagulants; Blood Coagulation; Blood Coagulation Factors; Dabigatran; Female; Fibrin; Healthy Volunteers; Hemostasis; Humans; Male; Middle Aged; Rivaroxaban; Single-Blind Method; Treatment Failure; Young Adult | 2015 |
14 other study(ies) available for dabigatran and fibrin
| Article | Year |
|---|---|
Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin-activatable fibrinolysis inhibitor.
Topics: Anticoagulants; Benzimidazoles; Carboxypeptidase B2; Dabigatran; Dose-Response Relationship, Drug; Fibrin; Fibrinolysis; Fibrinolytic Agents; Humans; Plant Proteins; Protease Inhibitors; Pyridines; Recombinant Proteins; Thrombin; Thrombomodulin; Time Factors; Tissue Plasminogen Activator | 2010 |
Fibrin formation by staphylothrombin facilitates Staphylococcus aureus-induced platelet aggregation.
Topics: Antithrombins; Benzimidazoles; beta-Alanine; Blood Platelets; Coagulase; Dabigatran; Fibrin; Hirudins; Humans; Integrin alpha2; Integrin beta3; Mutation; Platelet Aggregation; Platelet Function Tests; Receptors, IgG; Staphylococcus aureus; Thrombin; Time Factors; von Willebrand Factor | 2012 |
The ex vivo reversibility of dabigatran-induced whole-blood coagulopathy as monitored by thromboelastography: mechanistic implications for clinical medicine.
Topics: Antithrombins; Benzimidazoles; Blood Coagulation; Blood Coagulation Factors; Dabigatran; Drug Evaluation, Preclinical; Drug Monitoring; Factor VIIa; Fibrin; Hemorrhagic Disorders; Humans; In Vitro Techniques; Point-of-Care Systems; Pyridines; Recombinant Proteins; Thrombelastography; Thrombin; Whole Blood Coagulation Time | 2012 |
The role of staphylothrombin-mediated fibrin deposition in catheter-related Staphylococcus aureus infections.
Topics: Animals; Bacterial Adhesion; Bacterial Load; Benzimidazoles; beta-Alanine; Catheter-Related Infections; Central Venous Catheters; Coagulase; Dabigatran; Disease Models, Animal; Fibrin; Jugular Veins; Male; Mice; Mice, Inbred BALB C; Staphylococcal Infections; Thrombin | 2013 |
Comparative evaluation of direct thrombin and factor Xa inhibitors with antiplatelet agents under flow and static conditions: an in vitro flow chamber model.
Topics: Adenosine Triphosphate; Adult; Anticoagulants; Antithrombins; Aspirin; Benzimidazoles; beta-Alanine; Blood Platelets; Dabigatran; Dose-Response Relationship, Drug; Factor Xa; Factor Xa Inhibitors; Female; Fibrin; Humans; Lab-On-A-Chip Devices; Male; Microscopy, Confocal; Morpholines; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Rivaroxaban; Thiophenes; Thrombin; Thromboplastin; Thrombosis | 2014 |
Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in mice.
Topics: Alanine Transaminase; Animals; Benzimidazoles; beta-Alanine; Bile Acids and Salts; Dabigatran; Diet, High-Fat; Fatty Liver; Fibrin; Gene Expression; Inflammation; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Thrombin; Weight Gain | 2014 |
Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function.
Topics: Allosteric Regulation; Antithrombins; Arginine; Binding Sites; Biocatalysis; Blood Coagulation; Catalytic Domain; Dabigatran; Fibrin; Fibrinogen; Humans; Pipecolic Acids; Protein Binding; Substrate Specificity; Sulfonamides; Surface Plasmon Resonance; Thrombin | 2016 |
Thrombin contributes to protective immunity in pneumonia-derived sepsis via fibrin polymerization and platelet-neutrophil interactions.
Topics: Animals; Blood Coagulation; Blood Platelets; Cell Communication; Dabigatran; Extracellular Traps; Female; Fibrin; Fibrinogen; Flow Cytometry; Humans; Immune System; Immunity, Innate; Klebsiella Infections; Klebsiella pneumoniae; Lung; Mice; Mice, Inbred C57BL; Microcirculation; Neutrophils; Pneumonia, Bacterial; Sepsis; Thrombin | 2017 |
Thrombin promotes diet-induced obesity through fibrin-driven inflammation.
Topics: Adipose Tissue; Adiposity; Amino Acid Motifs; Animals; Blood Glucose; Body Composition; Body Weight; Coagulants; Dabigatran; Diet, High-Fat; Fatty Liver; Female; Fibrin; Genotype; Homozygote; Inflammation; Liver; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Obesity; Thrombin; Weight Gain | 2017 |
Dabigatran Reduces Liver Fibrosis in Thioacetamide-Injured Rats.
Topics: Animals; Antithrombins; Cell Line; Chemical and Drug Induced Liver Injury; Collagen; Cytoprotection; Dabigatran; Extracellular Signal-Regulated MAP Kinases; Fibrin; Hepatic Stellate Cells; Hypertension, Portal; Liver; Liver Cirrhosis, Experimental; Male; Neovascularization, Pathologic; Phosphorylation; Portal Pressure; Rats, Sprague-Dawley; Thioacetamide | 2019 |
[The clotting tests and molecular markers in evaluating of coagulation alterations against the background of anti-thrombotic prevention by Dabigatran after large orthopedic operations].
Topics: Anticoagulants; Arthroplasty, Replacement, Knee; Blood Coagulation; Blood Coagulation Tests; Dabigatran; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinopeptide A; Humans; Knee Joint; Male; Middle Aged; Postoperative Complications; Thrombin; Venous Thrombosis | 2017 |
Idarucizumab, but not procoagulant concentrates, fully restores dabigatran-altered platelet and fibrin components of hemostasis.
Topics: Animals; Antibodies, Monoclonal, Humanized; Blood Coagulation; Blood Platelets; Dabigatran; Female; Fibrin; Humans; Kinetics; Male; Platelet Aggregation; Rabbits; Thrombelastography | 2019 |
Long-Term Dabigatran Treatment Delays Alzheimer's Disease Pathogenesis in the TgCRND8 Mouse Model.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Anticoagulants; Blood-Brain Barrier; Cerebral Cortex; Dabigatran; Disease Models, Animal; Female; Fibrin; Hemostasis; Hippocampus; Maze Learning; Memory; Mice; Mice, Transgenic; Neurodegenerative Diseases; Perfusion; Thrombosis | 2019 |
Rivaroxaban Reduces the Dabigatran Dose Required for Anticoagulation During Simulated Cardiopulmonary Bypass.
Topics: Anticoagulants; Cardiopulmonary Bypass; Dabigatran; Fibrin; Heparin; Humans; Rivaroxaban; Thrombosis | 2022 |